"biopharma" - Google News

The Top 12 Companies Hiring in Biopharma Now - BioSpace

Thu, 02 Apr 2026 07:00:00 GMT

The Top 12 Companies Hiring in Biopharma Now BioSpace

March M&A surge triggers high expectations for 2026 - Fierce Pharma

Mon, 06 Apr 2026 09:00:00 GMT

March M&A surge triggers high expectations for 2026 Fierce Pharma

[EFFECT] Can-Fite BioPharma Ltd. SEC Filing - Stock Titan

Mon, 06 Apr 2026 10:07:33 GMT

[EFFECT] Can-Fite BioPharma Ltd. SEC Filing Stock Titan

AEON Biopharma, Inc. (AEON) stock price, news, quote and history - Yahoo Finance Australia

Sat, 04 Apr 2026 01:55:37 GMT

AEON Biopharma, Inc. (AEON) stock price, news, quote and history Yahoo Finance Australia

Theravance Biopharma (NASDAQ:TBPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

Mon, 06 Apr 2026 05:34:21 GMT

Theravance Biopharma (NASDAQ:TBPH) Lowered to "Buy" Rating by Wall Street Zen MarketBeat

Biopharma bites: Job cuts at Gilead, and Denali-Takeda deal demise - FirstWord Pharma

Fri, 03 Apr 2026 17:11:20 GMT

Biopharma bites: Job cuts at Gilead, and Denali-Takeda deal demise FirstWord Pharma

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Mon, 06 Apr 2026 06:32:00 GMT

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire

Biopharma R&D pipeline shrinks for 1st time in 30 years: report - Fierce Biotech

Fri, 03 Apr 2026 12:13:11 GMT

Biopharma R&D pipeline shrinks for 1st time in 30 years: report Fierce Biotech

Trump revives pharma tariffs with 100% charges, but leaves loopholes - BioPharma Dive

Fri, 03 Apr 2026 17:05:42 GMT

Trump revives pharma tariffs with 100% charges, but leaves loopholes BioPharma Dive

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit - Morningstar

Sun, 05 Apr 2026 20:59:00 GMT

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit Morningstar

Inside Virginia’s Rise to Biopharma Prominence - Virginia Economic Development Partnership

Wed, 01 Apr 2026 20:22:59 GMT

Inside Virginia’s Rise to Biopharma Prominence Virginia Economic Development Partnership

Drug Digest: Adaptive Trial Design and Regulatory Shifts in Biopharma Development - PharmTech.com

Fri, 03 Apr 2026 15:08:19 GMT

Drug Digest: Adaptive Trial Design and Regulatory Shifts in Biopharma Development PharmTech.com

Quantum Biopharma asks FDA to clear Phase 2 trial of Lucid-MS - Multiple Sclerosis News Today

Thu, 02 Apr 2026 16:09:19 GMT

Quantum Biopharma asks FDA to clear Phase 2 trial of Lucid-MS Multiple Sclerosis News Today

Binary High Pressure Gradient Liquid Chromatography System Market Forecast Points Higher Toward 2035, Driven by Biopharmaceutical Complexity - IndexBox

Mon, 06 Apr 2026 11:31:05 GMT

Binary High Pressure Gradient Liquid Chromatography System Market Forecast Points Higher Toward 2035, Driven by Biopharmaceutical Complexity IndexBox

The Quarterly Rx: Q1 2026 U.S. Biopharma Recap - William Blair

Wed, 01 Apr 2026 07:00:00 GMT

The Quarterly Rx: Q1 2026 U.S. Biopharma Recap William Blair

Grifols Plans IPO of U.S. Biopharma Business - wsj.com

Wed, 25 Mar 2026 07:00:00 GMT

Grifols Plans IPO of U.S. Biopharma Business wsj.com

GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology - Thailand Business News

Mon, 06 Apr 2026 07:06:37 GMT

GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology Thailand Business News

Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes - BioSpace

Wed, 01 Apr 2026 13:38:43 GMT

Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes BioSpace

‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1 - Fierce Biotech

Wed, 01 Apr 2026 12:42:56 GMT

‘There isn't as much meat left to cut’: Biopharma layoffs maintain slowdown in Q1 Fierce Biotech

Lilly beefs up neuroscience pipeline with $6.3B Centessa buyout - BioPharma Dive

Tue, 31 Mar 2026 16:07:17 GMT

Lilly beefs up neuroscience pipeline with $6.3B Centessa buyout BioPharma Dive

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire

Fri, 03 Apr 2026 15:33:00 GMT

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights Business Wire

Sunshine Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView

Fri, 03 Apr 2026 18:04:42 GMT

Sunshine Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary TradingView

Assessing Lepu Biopharma’s Valuation After Earnings Turnaround And Share Price Surge - simplywall.st

Sun, 05 Apr 2026 17:22:46 GMT

Assessing Lepu Biopharma’s Valuation After Earnings Turnaround And Share Price Surge simplywall.st

Massachusetts’ largest biopharma employer to lay off 237 in Cambridge - MassLive

Mon, 30 Mar 2026 15:38:00 GMT

Massachusetts’ largest biopharma employer to lay off 237 in Cambridge MassLive

MREO DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Mereo BioPharma Group plc Investors to Join the Class Action Lawsuit Today - ACCESS Newswire

Mon, 06 Apr 2026 11:49:19 GMT

MREO DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Mereo BioPharma Group plc Investors to Join the Class Action Lawsuit Today ACCESS Newswire

Matinas BioPharma has until May 2 to answer NYSE notice - Stock Titan

Fri, 03 Apr 2026 21:00:00 GMT

Matinas BioPharma has until May 2 to answer NYSE notice Stock Titan

Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Fri, 03 Apr 2026 21:03:01 GMT

Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView

Biopharma dealmaking in 2025 - Nature

Wed, 21 Jan 2026 08:00:00 GMT

Biopharma dealmaking in 2025 Nature

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire

Fri, 03 Apr 2026 21:00:00 GMT

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards GlobeNewswire

Saudi Arabia Biopharmaceutical Packaging Market: Cold Chain Innovation, Sterile Solutions & Growth Outlook - vocal.media

Mon, 06 Apr 2026 09:22:22 GMT

Saudi Arabia Biopharmaceutical Packaging Market: Cold Chain Innovation, Sterile Solutions & Growth Outlook vocal.media

Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M - Stock Titan

Fri, 03 Apr 2026 15:58:23 GMT

Sunshine Biopharma (NASDAQ: SBFM) 2025 revenue reaches $36.3M Stock Titan

The biopharma comeback is gaining momentum - Axios

Fri, 03 Apr 2026 21:08:05 GMT

The biopharma comeback is gaining momentum Axios

Grifols approves IPO of its US biopharma business - reuters.com

Tue, 24 Mar 2026 07:00:00 GMT

Grifols approves IPO of its US biopharma business reuters.com

Lilly’s AI commitment expands through deal with Insilico - BioPharma Dive

Mon, 30 Mar 2026 16:07:04 GMT

Lilly’s AI commitment expands through deal with Insilico BioPharma Dive

Smarter Raman QC for biopharma fill-finish with scalable model transfer - europeanpharmaceuticalreview.com

Wed, 01 Apr 2026 11:06:40 GMT

Smarter Raman QC for biopharma fill-finish with scalable model transfer europeanpharmaceuticalreview.com

Biopharma bites: Axsome adds an asset from Takeda, IO Biotech's farewell, and Evotec's new commercial leader - FirstWord Pharma

Wed, 01 Apr 2026 22:13:41 GMT

Biopharma bites: Axsome adds an asset from Takeda, IO Biotech's farewell, and Evotec's new commercial leader FirstWord Pharma

AEON Biopharma Received Notice of Noncompliance - TradingView

Fri, 03 Apr 2026 20:13:01 GMT

AEON Biopharma Received Notice of Noncompliance TradingView

Reimagining Business Models: Biopharma Trends 2026 - bcg.com

Thu, 08 Jan 2026 08:00:00 GMT

Reimagining Business Models: Biopharma Trends 2026 bcg.com

The emerging epicenter: Asia’s role in biopharma’s future - McKinsey & Company

Wed, 07 Jan 2026 08:00:00 GMT

The emerging epicenter: Asia’s role in biopharma’s future McKinsey & Company

AEON Biopharma (NYSE American: AEON) faces added NYSE equity noncompliance risk - Stock Titan

Fri, 03 Apr 2026 20:05:14 GMT

AEON Biopharma (NYSE American: AEON) faces added NYSE equity noncompliance risk Stock Titan

SK biopharmaceuticals to report preclinical data on NTSR1-targeted RPT at AACR 2026 - koreabiomed.com

Mon, 06 Apr 2026 04:30:51 GMT

SK biopharmaceuticals to report preclinical data on NTSR1-targeted RPT at AACR 2026 koreabiomed.com

Biopharma M&A: Outlook for 2026 - IQVIA

Mon, 19 Jan 2026 08:00:00 GMT

Biopharma M&A: Outlook for 2026 IQVIA

AEON stays on NYSE despite $55 million deficit as deadline nears - Stock Titan

Fri, 03 Apr 2026 20:05:00 GMT

AEON stays on NYSE despite $55 million deficit as deadline nears Stock Titan

Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors - The Manila Times

Mon, 06 Apr 2026 12:11:18 GMT

Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors The Manila Times

Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS - TradingView

Fri, 03 Apr 2026 16:05:02 GMT

Sunshine Biopharma 2025 10-K: $36.3M Revenue, $(1.44) EPS TradingView

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities - PR Newswire

Mon, 06 Apr 2026 11:00:00 GMT

Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities PR Newswire

Rethinking Patient Education for Emerging Biopharma - IQVIA

Mon, 30 Mar 2026 17:40:56 GMT

Rethinking Patient Education for Emerging Biopharma IQVIA

Immix Biopharma, Inc. (NASDAQ:IMMX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Fri, 03 Apr 2026 10:36:26 GMT

Immix Biopharma, Inc. (NASDAQ:IMMX) Receives Average Rating of "Moderate Buy" from Brokerages MarketBeat

New AEON finance chief gets stock awards tied to NYSE compliance - Stock Titan

Fri, 03 Apr 2026 20:10:00 GMT

New AEON finance chief gets stock awards tied to NYSE compliance Stock Titan

5 questions facing biopharma in 2026 - BioPharma Dive

Mon, 12 Jan 2026 08:00:00 GMT

5 questions facing biopharma in 2026 BioPharma Dive

Biopharma, Medtech Deal Reports for Q4 2025 - J.P. Morgan

Wed, 07 Jan 2026 08:00:00 GMT

Biopharma, Medtech Deal Reports for Q4 2025 J.P. Morgan

Unlocking Biopharma Innovation With Real-World Evidence - Clinical Leader

Mon, 30 Mar 2026 11:27:58 GMT

Unlocking Biopharma Innovation With Real-World Evidence Clinical Leader

AEON Biopharma Receives Additional NYSE American Noncompliance Notice - TipRanks

Fri, 03 Apr 2026 20:42:46 GMT

AEON Biopharma Receives Additional NYSE American Noncompliance Notice TipRanks

Sutro Biopharma Enters Sales Agreement, May Offer & Sell Shares Of Common Stock Of Up To $100 Million - SEC Filing - TradingView

Wed, 01 Apr 2026 21:28:08 GMT

Sutro Biopharma Enters Sales Agreement, May Offer & Sell Shares Of Common Stock Of Up To $100 Million - SEC Filing TradingView

In a banner year for biopharma, here are the best industry CEOs of 2025 - statnews.com

Tue, 16 Dec 2025 08:00:00 GMT

In a banner year for biopharma, here are the best industry CEOs of 2025 statnews.com

The top 10 biopharma M&A deals of 2025 - Fierce Pharma

Mon, 12 Jan 2026 08:00:00 GMT

The top 10 biopharma M&A deals of 2025 Fierce Pharma

Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline - Stock Titan

Fri, 03 Apr 2026 21:00:36 GMT

Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline Stock Titan

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 - PR Newswire

Fri, 03 Apr 2026 14:28:44 GMT

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 PR Newswire

Pfizer, BioNTech to pause COVID vaccine study due to low enrollment - BioPharma Dive

Wed, 01 Apr 2026 07:00:00 GMT

Pfizer, BioNTech to pause COVID vaccine study due to low enrollment BioPharma Dive

ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients - ImmunityBio

Fri, 20 Feb 2026 08:00:00 GMT

ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients ImmunityBio

Blackstone closes $6.3B fund for life sciences investing - BioPharma Dive

Mon, 30 Mar 2026 20:34:55 GMT

Blackstone closes $6.3B fund for life sciences investing BioPharma Dive

Agentic AI: Unlocking peak performance in biopharma development - McKinsey & Company

Thu, 11 Dec 2025 08:00:00 GMT

Agentic AI: Unlocking peak performance in biopharma development McKinsey & Company

Crescent Biopharma Stock Rockets 85% With 6-Day Winning Streak - trefis.com

Thu, 02 Apr 2026 05:04:14 GMT

Crescent Biopharma Stock Rockets 85% With 6-Day Winning Streak trefis.com

AEON Biopharma Receives Second NYSE American Notice for Listing Non-Compliance - geneonline.com

Sat, 04 Apr 2026 02:58:13 GMT

AEON Biopharma Receives Second NYSE American Notice for Listing Non-Compliance geneonline.com

Biopharma sector surges on innovation - China Daily

Thu, 02 Apr 2026 01:20:00 GMT

Biopharma sector surges on innovation China Daily

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know - Zacks Investment Research

Thu, 02 Apr 2026 13:33:38 GMT

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know Zacks Investment Research

Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions - PR Newswire

Tue, 03 Mar 2026 08:00:00 GMT

Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions PR Newswire

Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead - Fierce Biotech

Tue, 10 Mar 2026 07:00:00 GMT

Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead Fierce Biotech

The biopharma industry outlook on 2026: Optimism and tension - BioPharma Dive

Thu, 29 Jan 2026 08:00:00 GMT

The biopharma industry outlook on 2026: Optimism and tension BioPharma Dive

Biopharma’s Innovation Engine Powers Ahead, but Its Business Model Faces Mounting Strain - bcg.com

Thu, 08 Jan 2026 08:00:00 GMT

Biopharma’s Innovation Engine Powers Ahead, but Its Business Model Faces Mounting Strain bcg.com

Viridian tumbles on positive data for key eye drug prospect - BioPharma Dive

Tue, 31 Mar 2026 20:44:28 GMT

Viridian tumbles on positive data for key eye drug prospect BioPharma Dive

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO - PR Newswire

Wed, 01 Apr 2026 13:00:00 GMT

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO PR Newswire

Quantum BioPharma (QNTM) advances Lucid-MS with FDA IND for Phase 2 MS trial - Stock Titan

Wed, 01 Apr 2026 12:02:04 GMT

Quantum BioPharma (QNTM) advances Lucid-MS with FDA IND for Phase 2 MS trial Stock Titan

The Quarterly Rx: 2025 U.S. Biopharma Recap - William Blair

Tue, 23 Dec 2025 08:00:00 GMT

The Quarterly Rx: 2025 U.S. Biopharma Recap William Blair

Closing the gender health gap: How biopharma R&D can take action - The World Economic Forum

Thu, 22 Jan 2026 08:00:00 GMT

Closing the gender health gap: How biopharma R&D can take action The World Economic Forum

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Fri, 03 Apr 2026 20:15:00 GMT

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire

Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets - BioPharma Dive

Wed, 01 Apr 2026 21:17:18 GMT

Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets BioPharma Dive

India budget bets on biopharma and space push ahead of human missions - Nature

Sun, 01 Feb 2026 08:00:00 GMT

India budget bets on biopharma and space push ahead of human missions Nature

Agentic AI in Biopharma: Game-changing Efficiency - bcg.com

Mon, 10 Nov 2025 08:00:00 GMT

Agentic AI in Biopharma: Game-changing Efficiency bcg.com

Hunting for biopharma’s innovation sweet spot - Nature

Wed, 28 Jan 2026 08:00:00 GMT

Hunting for biopharma’s innovation sweet spot Nature

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics - PR Newswire

Thu, 04 Dec 2025 08:00:00 GMT

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics PR Newswire

Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA - Fierce Biotech

Thu, 26 Mar 2026 07:00:00 GMT

Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA Fierce Biotech

The AI-First Biopharma Company - bcg.com

Fri, 02 Jan 2026 08:00:00 GMT

The AI-First Biopharma Company bcg.com

MREO Investors Have Opportunity to Lead Mereo BioPharma - GlobeNewswire

Thu, 02 Apr 2026 14:17:33 GMT

MREO Investors Have Opportunity to Lead Mereo BioPharma GlobeNewswire

Quantum BioPharma submits IND application for MS drug candidate - Investing.com

Wed, 01 Apr 2026 12:32:38 GMT

Quantum BioPharma submits IND application for MS drug candidate Investing.com

Xeris Biopharma Approves Inducement Grants for 50,000 Shares to Two New Employees - geneonline.com

Fri, 03 Apr 2026 21:33:41 GMT

Xeris Biopharma Approves Inducement Grants for 50,000 Shares to Two New Employees geneonline.com

FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma's Biosimilar to NEUPOGEN® (filgrastim) - PR Newswire

Tue, 17 Feb 2026 08:00:00 GMT

FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma's Biosimilar to NEUPOGEN® (filgrastim) PR Newswire

How AI in biopharma drives mission‑focused growth - EY

Fri, 06 Feb 2026 08:00:00 GMT

How AI in biopharma drives mission‑focused growth EY

FDA approves Lilly obesity pill, triggering battle with Novo Nordisk - BioPharma Dive

Thu, 02 Apr 2026 00:13:48 GMT

FDA approves Lilly obesity pill, triggering battle with Novo Nordisk BioPharma Dive

Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump - BioPharma Dive

Mon, 22 Dec 2025 08:00:00 GMT

Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump BioPharma Dive

Quantum Biopharma Provides Corporate Update - Yahoo Finance

Fri, 27 Mar 2026 23:30:00 GMT

Quantum Biopharma Provides Corporate Update Yahoo Finance

Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook - Fierce Biotech

Mon, 16 Feb 2026 08:00:00 GMT

Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook Fierce Biotech

Biogen, with $5.6B Apellis buy, builds out immunology offerings - BioPharma Dive

Tue, 31 Mar 2026 16:17:17 GMT

Biogen, with $5.6B Apellis buy, builds out immunology offerings BioPharma Dive

Meet Enablon at the 3rd Annual EHS for Biopharma Summit - Wolters Kluwer

Tue, 10 Mar 2026 11:54:34 GMT

Meet Enablon at the 3rd Annual EHS for Biopharma Summit Wolters Kluwer

From Lab Bench to Biopharma | Arts & Sciences - Boston University

Fri, 27 Feb 2026 08:00:00 GMT

From Lab Bench to Biopharma | Arts & Sciences Boston University

Quantum BioPharma pushes MS drug toward Phase 2 with FDA filing - Stock Titan

Wed, 01 Apr 2026 12:02:00 GMT

Quantum BioPharma pushes MS drug toward Phase 2 with FDA filing Stock Titan

China Is Increasing Its Share of Global Drug Development - Goldman Sachs

Wed, 17 Dec 2025 08:00:00 GMT

China Is Increasing Its Share of Global Drug Development Goldman Sachs

News Roundup: Biopharma funding report released - Massachusetts Biotechnology Council

Mon, 12 Jan 2026 08:00:00 GMT

News Roundup: Biopharma funding report released Massachusetts Biotechnology Council

Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech

Wed, 04 Mar 2026 08:00:00 GMT

Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' Fierce Biotech

Trump Pharma Tariffs: Wrong Rx for U.S. Patients, Manufacturing, and Innovation | Blogs | Apr 3, 2026 - Information Technology and Innovation Foundation (ITIF)

Fri, 03 Apr 2026 20:35:04 GMT

Trump Pharma Tariffs: Wrong Rx for U.S. Patients, Manufacturing, and Innovation | Blogs | Apr 3, 2026 Information Technology and Innovation Foundation (ITIF)